PHILOGEN

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation ...
Read all

NEWS

Philogen S.p.A. announced that the European Commission (EC) has granted Orphan Drug Designation to L19TNF for the treatment of soft-tissue sarcoma.

PIPELINE

Philogen is a fully integrated company active in the discovery, GMP production and clinical development of immunomodulatory biopharmaceuticals. We have a leading position in the field of antibody-based therapeutics ...
Read all

PARTNERS

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.